Cytokinetics Stock Forecast - Accumulation Distribution

CYTK Stock  USD 62.51  0.81  1.28%   
Cytokinetics Stock Forecast is based on your current time horizon. Although Cytokinetics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Cytokinetics' systematic risk associated with finding meaningful patterns of Cytokinetics fundamentals over time.
As of now the rsi of Cytokinetics' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Cytokinetics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Cytokinetics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Cytokinetics' stock price prediction:
EPS Estimate Next Quarter
(1.57)
EPS Estimate Current Year
(6.09)
EPS Estimate Next Year
(5.86)
Wall Street Target Price
86.6111
EPS Estimate Current Quarter
(1.63)
Using Cytokinetics hype-based prediction, you can estimate the value of Cytokinetics from the perspective of Cytokinetics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Cytokinetics using Cytokinetics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Cytokinetics using crowd psychology based on the activity and movement of Cytokinetics' stock price.

Cytokinetics Short Interest

An investor who is long Cytokinetics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Cytokinetics and may potentially protect profits, hedge Cytokinetics with its derivative instruments, or be ready for some potential downside.
200 Day MA
46.3427
Short Percent
0.1413
Short Ratio
7.6
Shares Short Prior Month
12.9 M
50 Day MA
63.3508

Cytokinetics Hype to Price Pattern

Investor biases related to Cytokinetics' public news can be used to forecast risks associated with an investment in Cytokinetics. The trend in average sentiment can be used to explain how an investor holding Cytokinetics can time the market purely based on public headlines and social activities around Cytokinetics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Cytokinetics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Cytokinetics.

Cytokinetics Implied Volatility

    
  0.93  
Cytokinetics' implied volatility exposes the market's sentiment of Cytokinetics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cytokinetics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cytokinetics stock will not fluctuate a lot when Cytokinetics' options are near their expiration.

Cytokinetics after-hype prediction price

    
  USD 63.26  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Cytokinetics to cross-verify your projections.
For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.The value of Inventory Turnover is estimated to slide to -12.41. The value of Payables Turnover is estimated to slide to 17.85. Common Stock Shares Outstanding is expected to rise to about 135.2 M this year, although the value of Net Loss is projected to rise to (332.6 M).

Open Interest Against 2026-04-17 Cytokinetics Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Cytokinetics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Cytokinetics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Cytokinetics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Cytokinetics' open interest, investors have to compare it to Cytokinetics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Cytokinetics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Cytokinetics. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.

Cytokinetics Additional Predictive Modules

Most predictive techniques to examine Cytokinetics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cytokinetics using various technical indicators. When you analyze Cytokinetics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cytokinetics has current Accumulation Distribution of 102780.0. The accumulation distribution (A/D) indicator shows the degree to which Cytokinetics is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Cytokinetics to determine if accumulation or reduction is taking place in the market. This value is adjusted by Cytokinetics trading volume to give more weight to distributions with higher volume over lower volume.
Check Cytokinetics VolatilityBacktest CytokineticsInformation Ratio  

Cytokinetics Trading Date Momentum

On January 09 2026 Cytokinetics was traded for  62.51  at the closing time. The top price for the day was 64.97  and the lowest listed price was  62.28 . The trading volume for the day was 2.5 M. The trading history from January 9, 2026 did not affect price variability. The overall trading delta against the current closing price is 1.30% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Cytokinetics to competition

Other Forecasting Options for Cytokinetics

For every potential investor in Cytokinetics, whether a beginner or expert, Cytokinetics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cytokinetics Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cytokinetics. Basic forecasting techniques help filter out the noise by identifying Cytokinetics' price trends.

Cytokinetics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cytokinetics stock to make a market-neutral strategy. Peer analysis of Cytokinetics could also be used in its relative valuation, which is a method of valuing Cytokinetics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Cytokinetics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Cytokinetics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Cytokinetics' current price.

Cytokinetics Market Strength Events

Market strength indicators help investors to evaluate how Cytokinetics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cytokinetics shares will generate the highest return on investment. By undertsting and applying Cytokinetics stock market strength indicators, traders can identify Cytokinetics entry and exit signals to maximize returns.

Cytokinetics Risk Indicators

The analysis of Cytokinetics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cytokinetics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cytokinetics stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Cytokinetics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Cytokinetics Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Cytokinetics Stock. Highlighted below are key reports to facilitate an investment decision about Cytokinetics Stock:
Check out Historical Fundamental Analysis of Cytokinetics to cross-verify your projections.
For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. If investors know Cytokinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytokinetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.30)
Revenue Per Share
0.733
Quarterly Revenue Growth
3.181
Return On Assets
(0.25)
Return On Equity
(5.72)
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytokinetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytokinetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytokinetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.